These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35307806)

  • 21. Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response.
    Gupta VG; Rangaraju RR; Saha R; Bajpai P
    J Gastrointest Cancer; 2019 Dec; 50(4):943-946. PubMed ID: 29961919
    [No Abstract]   [Full Text] [Related]  

  • 22. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASO Author Reflections: Use of the Survival Recurrent Network for Prediction of Overall Survival in Patients with Gastric Cancer.
    Oh SE; Choi MG; Seo SW
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):539-540. PubMed ID: 30539490
    [No Abstract]   [Full Text] [Related]  

  • 24. [Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
    Lordick F; Ott K; Krause BJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1061-6. PubMed ID: 21560108
    [No Abstract]   [Full Text] [Related]  

  • 25. The Management of Esophagogastric Cancers Enters a New Era.
    Shah MA
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):xiii-xiv. PubMed ID: 28501094
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
    Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
    World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Current Status of Immunotherapies in Esophagogastric Cancer.
    Ku GY
    Surg Oncol Clin N Am; 2017 Apr; 26(2):277-292. PubMed ID: 28279469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASO Author Reflections: Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer.
    Shiraishi O
    Ann Surg Oncol; 2020 Oct; 27(11):4441-4442. PubMed ID: 32451946
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis and treatment of esophagogastric junction cancer].
    Seto Y; Yamashita H
    Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1769-75. PubMed ID: 26440679
    [No Abstract]   [Full Text] [Related]  

  • 30. [Positron emission tomography in tumors of the upper gastrointestinal tract: controversial value].
    Vallböhmer D; Hölscher AH
    Dtsch Med Wochenschr; 2011 May; 136(20):1060. PubMed ID: 21560107
    [No Abstract]   [Full Text] [Related]  

  • 31. [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
    Moehler M; Al-Batran SE; Andus T; Anthuber M; Arends J; Arnold D; Aust D; Baier P; Baretton G; Bernhardt J; Boeing H; Böhle E; Bokemeyer C; Bornschein J; Budach W; Burmester E; Caca K; Diemer WA; Dietrich CF; Ebert M; Eickhoff A; Ell C; Fahlke J; Feussner H; Fietkau R; Fischbach W; Fleig W; Flentje M; Gabbert HE; Galle PR; Geissler M; Gockel I; Graeven U; Grenacher L; Gross S; Hartmann JT; Heike M; Heinemann V; Herbst B; Herrmann T; Höcht S; Hofheinz RD; Höfler H; Höhler T; Hölscher AH; Horneber M; Hübner J; Izbicki JR; Jakobs R; Jenssen C; Kanzler S; Keller M; Kiesslich R; Klautke G; Körber J; Krause BJ; Kuhn C; Kullmann F; Lang H; Link H; Lordick F; Ludwig K; Lutz M; Mahlberg R; Malfertheiner P; Merkel S; Messmann H; Meyer HJ; Mönig S; Piso P; Pistorius S; Porschen R; Rabenstein T; Reichardt P; Ridwelski K; Röcken C; Roetzer I; Rohr P; Schepp W; Schlag PM; Schmid RM; Schmidberger H; Schmiegel WH; Schmoll HJ; Schuch G; Schuhmacher C; Schütte K; Schwenk W; Selgrad M; Sendler A; Seraphin J; Seufferlein T; Stahl M; Stein H; Stoll C; Stuschke M; Tannapfel A; Tholen R; Thuss-Patience P; Treml K; Vanhoefer U; Vieth M; Vogelsang H; Wagner D; Wedding U; Weimann A; Wilke H; Wittekind C; ;
    Z Gastroenterol; 2011 Apr; 49(4):461-531. PubMed ID: 21476183
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event.
    La Mendola R; Bencivenga M; Torroni L; Sacco M; Giacopuzzi S
    Ann Surg Oncol; 2021 Jun; 28(6):3044-3045. PubMed ID: 33175259
    [No Abstract]   [Full Text] [Related]  

  • 33. Esophageal and esophagogastric junction cancers, version 1.2015.
    Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Besh S; Chao J; Das P; Denlinger C; Fanta P; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Jasperson K; Keswani RN; Kleinberg LR; Korn WM; Leong S; Lockhart AC; Mulcahy MF; Orringer MB; Posey JA; Poultsides GA; Sasson AR; Scott WJ; Strong VE; Varghese TK; Washington MK; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H;
    J Natl Compr Canc Netw; 2015 Feb; 13(2):194-227. PubMed ID: 25691612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophagogastric junction and gastric adenocarcinoma: current challenges and future directions.
    Saba NF
    Oncology (Williston Park); 2014 Jun; 28(6):520-1. PubMed ID: 25134327
    [No Abstract]   [Full Text] [Related]  

  • 35. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASO Author Reflections: Advanced and Recurrent Pelvic Squamous Cell Cancer: Unfinished Business.
    Waters PS; Warrier SK; Heriot AG
    Ann Surg Oncol; 2020 Jul; 27(7):2457-2458. PubMed ID: 32180065
    [No Abstract]   [Full Text] [Related]  

  • 37. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis.
    Kroese TE; van Laarhoven HWM; Nilsson M; Lordick F; Guckenberger M; Ruurda JP; D'Ugo D; Haustermans K; van Cutsem E; van Hillegersberg R; van Rossum PSN
    Eur J Cancer; 2022 May; 166():254-269. PubMed ID: 35339868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What's New in Gastric and Esophageal Cancers.
    Tanabe K
    Ann Surg Oncol; 2016 Nov; 23(12):3773. PubMed ID: 27638669
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].
    Gockel I; Lordick F; Lyros O; Kreuser N; Hölscher AH; Wittekind C
    Chirurg; 2020 Jan; 91(1):41-50. PubMed ID: 31372677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EURECCA oesophago-gastric cancer project.
    Allum W; Osorio J
    Cir Esp; 2016 May; 94(5):255-6. PubMed ID: 26944535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.